NCT01721811

Brief Summary

The aim of the study is to investigate how the retina adapts to different metabolic challenges, e.g. chronic systemic hypoxia, hyperglycemia, special training conditions or diets as well as transient changes in the content of oxygen and glucose in the blood.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2012

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

October 31, 2012

Completed
6 days until next milestone

First Posted

Study publicly available on registry

November 6, 2012

Completed
3.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2015

Completed
Last Updated

March 11, 2015

Status Verified

March 1, 2015

Enrollment Period

3.2 years

First QC Date

October 31, 2012

Last Update Submit

March 10, 2015

Conditions

Outcome Measures

Primary Outcomes (6)

  • Retinal vessel diameters during hyperoxia

    Measurement of retinal vessel diameters before, during and after hyperoxic stimulation.

    Before hyperoxia, after 15 minutes of hyperoxia, 30 minutes after ending hyperoxia

  • Retinal perfusion velocities during hyperoxia

    Measurement of retinal perfusion velocities before, during and after hyperoxic stimulation.

    Before hyperoxia, after 15 minutes of hyperoxia, 30 minutes after ending hyperoxia

  • Retinal oximetry during hyperoxia

    Measurement of retinal oximetry status before, during and after hyperoxic stimulation.

    Before hyperoxia, after 15 minutes of hyperoxia, 30 minutes after ending hyperoxia

  • Retinal vessel diameters during hyperglycemia

    Measurement of retinal vessel diameters before, during and after hyperglycemic stimulation.

    Before glucose ingestion, every 30 minutes for 3 hours following oral glucose load

  • Retinal perfusion during hyperglycemia

    Measurement of retinal perfusion velocities before, during and after hyperglycemic stimulation.

    Before glucose ingestion, every 30 minutes for 3 hours following oral glucose load

  • Retinal oximetry during hyperglycemia

    Measurement of retinal oximetry status before, during and after hyperglycemic stimulation.

    Before glucose ingestion, every 30 minutes for 3 hours following oral glucose load

Study Arms (2)

Healthy

EXPERIMENTAL

Healthy study participanats

Other: HyperoxiaOther: Glucose

Diabetes

EXPERIMENTAL

Patients with diabetes

Other: HyperoxiaOther: Glucose

Interventions

Also known as: Hyperoxia is achieved by short-term pure oxygen breathing.
DiabetesHealthy
GlucoseOTHER
Also known as: Standardised oral glucose load.
DiabetesHealthy

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Healthy volunteers.
  • No known systemic or ocular disease.

You may not qualify if:

  • Any systemic or ocular disease.
  • Patients with diabetes
  • Diabetes mellitus
  • No intraocular disease other than conditions attributable to diabetes.
  • Intraocular disease other than conditions attributable to diabetes.
  • Systemic conditions which might contraindicate hyperoxic stimulation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Ophthalmology, Glostrup University Hospital

Glostrup Municipality, 2600, Denmark

RECRUITING

MeSH Terms

Interventions

Glucose

Intervention Hierarchy (Ancestors)

HexosesMonosaccharidesSugarsCarbohydrates

Study Officials

  • Oliver Klefter, MD

    Glostrup UH

    PRINCIPAL INVESTIGATOR
  • Michael Larsen, Professor, DMSci

    Glostrup UH

    STUDY DIRECTOR

Central Study Contacts

Oliver Klefter, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

October 31, 2012

First Posted

November 6, 2012

Study Start

October 1, 2012

Primary Completion

December 1, 2015

Last Updated

March 11, 2015

Record last verified: 2015-03

Locations